These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease. Kang SS; Wong PW; Cook HY; Norusis M; Messer JV J Clin Invest; 1986 May; 77(5):1482-6. PubMed ID: 3700650 [TBL] [Abstract][Full Text] [Related]
9. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. Taylor LM; DeFrang RD; Harris EJ; Porter JM J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384 [TBL] [Abstract][Full Text] [Related]
10. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go? Spence JD Am J Cardiovasc Drugs; 2001; 1(2):85-9. PubMed ID: 14728038 [TBL] [Abstract][Full Text] [Related]
18. The effect of D-penicillamine on protein-bound homocyst(e)ine in homocystinurics. Kang SS; Wong PW; Curley K Pediatr Res; 1982 May; 16(5):370-2. PubMed ID: 7099755 [TBL] [Abstract][Full Text] [Related]
19. Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation. Sengupta S; Wehbe C; Majors AK; Ketterer ME; DiBello PM; Jacobsen DW J Biol Chem; 2001 Dec; 276(50):46896-904. PubMed ID: 11592966 [TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Galis ZS; Muszynski M; Sukhova GK; Simon-Morrissey E; Libby P Ann N Y Acad Sci; 1995 Jan; 748():501-7. PubMed ID: 7695193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]